ID   NSMA2_HUMAN             Reviewed;         655 AA.
AC   Q9NY59; B7ZL82; Q2M1S8;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   15-MAR-2017, entry version 122.
DE   RecName: Full=Sphingomyelin phosphodiesterase 3;
DE            EC=3.1.4.12;
DE   AltName: Full=Neutral sphingomyelinase 2;
DE            Short=nSMase-2;
DE            Short=nSMase2;
DE   AltName: Full=Neutral sphingomyelinase II;
GN   Name=SMPD3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, COFACTOR, ENZYME
RP   REGULATION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10823942; DOI=10.1073/pnas.97.11.5895;
RA   Hofmann K., Tomiuk S., Wolff G., Stoffel W.;
RT   "Cloning and characterization of the mammalian brain-specific, Mg2+-
RT   dependent neutral sphingomyelinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:5895-5900(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION.
RX   PubMed=14741383; DOI=10.1016/S0014-5793(03)01523-0;
RA   Miura Y., Gotoh E., Nara F., Nishijima M., Hanada K.;
RT   "Hydrolysis of sphingosylphosphocholine by neutral
RT   sphingomyelinases.";
RL   FEBS Lett. 557:288-292(2004).
RN   [5]
RP   FUNCTION, COFACTOR, AND SUBCELLULAR LOCATION.
RX   PubMed=15051724; DOI=10.1074/jbc.M313662200;
RA   Marchesini N., Osta W., Bielawski J., Luberto C., Obeid L.M.,
RA   Hannun Y.A.;
RT   "Role for mammalian neutral sphingomyelinase 2 in confluence-induced
RT   growth arrest of MCF7 cells.";
RL   J. Biol. Chem. 279:25101-25111(2004).
RN   [6]
RP   TOPOLOGY.
RX   PubMed=17349629; DOI=10.1016/j.febslet.2007.02.046;
RA   Tani M., Hannun Y.A.;
RT   "Analysis of membrane topology of neutral sphingomyelinase 2.";
RL   FEBS Lett. 581:1323-1328(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-291, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Catalyzes the hydrolysis of sphingomyelin to form
CC       ceramide and phosphocholine. Ceramide mediates numerous cellular
CC       functions, such as apoptosis and growth arrest, and is capable of
CC       regulating these 2 cellular events independently. Also hydrolyzes
CC       sphingosylphosphocholine. Regulates the cell cycle by acting as a
CC       growth suppressor in confluent cells. Probably acts as a regulator
CC       of postnatal development and participates in bone and dentin
CC       mineralization. {ECO:0000269|PubMed:10823942,
CC       ECO:0000269|PubMed:14741383, ECO:0000269|PubMed:15051724}.
CC   -!- CATALYTIC ACTIVITY: Sphingomyelin + H(2)O = N-acylsphingosine +
CC       phosphocholine.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:10823942,
CC         ECO:0000269|PubMed:15051724};
CC   -!- ENZYME REGULATION: Activated by unsaturated fatty acids and
CC       phosphatidylserine. {ECO:0000269|PubMed:10823942}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 7.5.;
CC   -!- PATHWAY: Lipid metabolism; sphingolipid metabolism.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:10823942}; Lipid-anchor
CC       {ECO:0000269|PubMed:10823942}. Cell membrane
CC       {ECO:0000269|PubMed:15051724}; Lipid-anchor
CC       {ECO:0000269|PubMed:15051724}. Note=May localize to detergent-
CC       resistant subdomains of Golgi membranes of hypothalamic
CC       neurosecretory neurons (PubMed:10823942). Localizes to plasma
CC       membrane in confluent contact-inhaibited cells (PubMed:15051724).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NY59-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NY59-2; Sequence=VSP_054334;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in brain.
CC       {ECO:0000269|PubMed:10823942}.
CC   -!- DEVELOPMENTAL STAGE: Up-regulated during G0/G1 phases.
CC   -!- PTM: Palmitoylated, palmitoylation-deficient proteins are targeted
CC       for lysosomal degradation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the neutral sphingomyelinase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ250460; CAB92964.1; -; mRNA.
DR   EMBL; AC099521; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC112238; AAI12239.1; -; mRNA.
DR   EMBL; BC143631; AAI43632.1; -; mRNA.
DR   CCDS; CCDS10867.1; -. [Q9NY59-1]
DR   RefSeq; NP_061137.1; NM_018667.3. [Q9NY59-1]
DR   RefSeq; XP_005256088.1; XM_005256031.3. [Q9NY59-1]
DR   RefSeq; XP_005256089.1; XM_005256032.3. [Q9NY59-1]
DR   RefSeq; XP_011521509.1; XM_011523207.1. [Q9NY59-1]
DR   RefSeq; XP_011521510.1; XM_011523208.2. [Q9NY59-1]
DR   RefSeq; XP_011521511.1; XM_011523209.2. [Q9NY59-1]
DR   RefSeq; XP_016878894.1; XM_017023405.1. [Q9NY59-1]
DR   RefSeq; XP_016878895.1; XM_017023406.1. [Q9NY59-1]
DR   RefSeq; XP_016878896.1; XM_017023407.1. [Q9NY59-1]
DR   RefSeq; XP_016878897.1; XM_017023408.1. [Q9NY59-1]
DR   UniGene; Hs.368421; -.
DR   ProteinModelPortal; Q9NY59; -.
DR   SMR; Q9NY59; -.
DR   BioGrid; 120692; 9.
DR   DIP; DIP-60431N; -.
DR   IntAct; Q9NY59; 10.
DR   STRING; 9606.ENSP00000219334; -.
DR   DrugBank; DB00144; Phosphatidyl serine.
DR   SwissLipids; SLP:000001111; -.
DR   iPTMnet; Q9NY59; -.
DR   PhosphoSitePlus; Q9NY59; -.
DR   SwissPalm; Q9NY59; -.
DR   BioMuta; SMPD3; -.
DR   DMDM; 73921262; -.
DR   PaxDb; Q9NY59; -.
DR   PeptideAtlas; Q9NY59; -.
DR   PRIDE; Q9NY59; -.
DR   DNASU; 55512; -.
DR   Ensembl; ENST00000219334; ENSP00000219334; ENSG00000103056. [Q9NY59-1]
DR   Ensembl; ENST00000563226; ENSP00000455955; ENSG00000103056. [Q9NY59-2]
DR   GeneID; 55512; -.
DR   KEGG; hsa:55512; -.
DR   UCSC; uc002ewa.4; human. [Q9NY59-1]
DR   CTD; 55512; -.
DR   DisGeNET; 55512; -.
DR   GeneCards; SMPD3; -.
DR   HGNC; HGNC:14240; SMPD3.
DR   HPA; CAB033885; -.
DR   HPA; HPA065535; -.
DR   HPA; HPA069383; -.
DR   MIM; 605777; gene.
DR   neXtProt; NX_Q9NY59; -.
DR   OpenTargets; ENSG00000103056; -.
DR   PharmGKB; PA37862; -.
DR   eggNOG; ENOG410IEKS; Eukaryota.
DR   eggNOG; ENOG41104QW; LUCA.
DR   GeneTree; ENSGT00400000022168; -.
DR   HOGENOM; HOG000049296; -.
DR   HOVERGEN; HBG079416; -.
DR   InParanoid; Q9NY59; -.
DR   KO; K12352; -.
DR   OMA; PNSCLSA; -.
DR   OrthoDB; EOG091G0RKM; -.
DR   PhylomeDB; Q9NY59; -.
DR   TreeFam; TF328678; -.
DR   BRENDA; 3.1.4.12; 2681.
DR   Reactome; R-HSA-1660662; Glycosphingolipid metabolism.
DR   Reactome; R-HSA-5626978; TNFR1-mediated ceramide production.
DR   UniPathway; UPA00222; -.
DR   GeneWiki; SMPD3; -.
DR   GenomeRNAi; 55512; -.
DR   PRO; PR:Q9NY59; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000103056; -.
DR   CleanEx; HS_SMPD3; -.
DR   ExpressionAtlas; Q9NY59; baseline and differential.
DR   Genevisible; Q9NY59; HS.
DR   GO; GO:0000137; C:Golgi cis cisterna; IEA:Ensembl.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004767; F:sphingomyelin phosphodiesterase activity; IEA:UniProtKB-EC.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl.
DR   GO; GO:0030072; P:peptide hormone secretion; IEA:Ensembl.
DR   GO; GO:2000304; P:positive regulation of ceramide biosynthetic process; TAS:Reactome.
DR   GO; GO:1903543; P:positive regulation of exosomal secretion; ISS:BHF-UCL.
DR   GO; GO:0006685; P:sphingomyelin catabolic process; TAS:ProtInc.
DR   Gene3D; 3.60.10.10; -; 1.
DR   InterPro; IPR005135; Endo/exonuclease/phosphatase.
DR   Pfam; PF03372; Exo_endo_phos; 1.
DR   SUPFAM; SSF56219; SSF56219; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Cell membrane; Complete proteome;
KW   Developmental protein; Golgi apparatus; Hydrolase; Lipid metabolism;
KW   Lipoprotein; Magnesium; Membrane; Metal-binding; Palmitate;
KW   Phosphoprotein; Reference proteome; Sphingolipid metabolism.
FT   CHAIN         1    655       Sphingomyelin phosphodiesterase 3.
FT                                /FTId=PRO_0000075692.
FT   TOPO_DOM      1     10       Cytoplasmic. {ECO:0000255}.
FT   INTRAMEM     11     31       Helical. {ECO:0000255}.
FT   TOPO_DOM     32     64       Cytoplasmic. {ECO:0000255}.
FT   INTRAMEM     65     85       Helical. {ECO:0000255}.
FT   TOPO_DOM     86    655       Cytoplasmic. {ECO:0000255}.
FT   ACT_SITE    639    639       Proton acceptor. {ECO:0000250}.
FT   METAL       364    364       Magnesium. {ECO:0000250}.
FT   SITE        512    512       Important for substrate recognition.
FT                                {ECO:0000250}.
FT   MOD_RES     178    178       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JJY3}.
FT   MOD_RES     291    291       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   LIPID        53     53       S-palmitoyl cysteine. {ECO:0000250}.
FT   LIPID        54     54       S-palmitoyl cysteine. {ECO:0000250}.
FT   LIPID        59     59       S-palmitoyl cysteine. {ECO:0000250}.
FT   LIPID       397    397       S-palmitoyl cysteine. {ECO:0000250}.
FT   LIPID       398    398       S-palmitoyl cysteine. {ECO:0000250}.
FT   VAR_SEQ     541    548       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054334.
SQ   SEQUENCE   655 AA;  71081 MW;  C06401571633C48E CRC64;
     MVLYTTPFPN SCLSALHCVS WALIFPCYWL VDRLAASFIP TTYEKRQRAD DPCCLQLLCT
     ALFTPIYLAL LVASLPFAFL GFLFWSPLQS ARRPYIYSRL EDKGLAGGAA LLSEWKGTGP
     GKSFCFATAN VCLLPDSLAR VNNLFNTQAR AKEIGQRIRN GAARPQIKIY IDSPTNTSIS
     AASFSSLVSP QGGDGVARAV PGSIKRTASV EYKGDGGRHP GDEAANGPAS GDPVDSSSPE
     DACIVRIGGE EGGRPPEADD PVPGGQARNG AGGGPRGQTP NHNQQDGDSG SLGSPSASRE
     SLVKGRAGPD TSASGEPGAN SKLLYKASVV KKAAARRRRH PDEAFDHEVS AFFPANLDFL
     CLQEVFDKRA ATKLKEQLHG YFEYILYDVG VYGCQGCCSF KCLNSGLLFA SRYPIMDVAY
     HCYPNKCNDD ALASKGALFL KVQVGSTPQD QRIVGYIACT HLHAPQEDSA IRCGQLDLLQ
     DWLADFRKST SSSSAANPEE LVAFDVVCGD FNFDNCSSDD KLEQQHSLFT HYRDPCRLGP
     GEEKPWAIGT LLDTNGLYDE DVCTPDNLQK VLESEEGRRE YLAFPTSKSS GQKGRKELLK
     GNGRRIDYML HAEEGLCPDW KAEVEEFSFI TQLSGLTDHL PVAMRLMVSS GEEEA
//
